Insider Buy: Molecular Templates
5:27PM ET 6/21/2022 MT NewswiresKevin M. Lalande, 10% Owner, Director, on June 13, 2022, executed a purchase for 222,000 shares in Molecular Templates (MTEM) for $198,380. Following the...
Kevin M. Lalande, 10% Owner, Director, on June 13, 2022, executed a purchase for 222,000 shares in Molecular Templates (MTEM) for $198,380. Following the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Molecular Templates (MTEM) has an average rating of buy and price targets ranging from $4.50 to $18, according to analysts polled by Capital IQ. (MT...
...
Address | 9301 Amberglen Boulevard Austin, Texas 78729 |
Phone | +1.512.869.1555 |
Number of Employees | 68 |
Director, Chief Executive & Scientific Officer | Eric E. Poma |
President & Chief Operating Officer | Jason S. Kim |
CFO, Senior Vice President & Controller | Sean McLennan |
Chief Medical Officer | Roger J. Waltzman |
Price Open | $0.91 |
Previous Close | $0.91 |
52 Week Range | $0.76 - 8.29 |
Market Capitalization | $48.9 M |
Shares Outstanding | 56.3 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 08/11/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$1.38 |
Beta vs. S&P 500 | N/A |
Revenue | $13.3 M |
Net Profit Margin | -177.06% |
Return on Equity | -110.16% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |